International journal of speech-language pathology · 2026
Is iohexol an acceptable alternative to barium sulphate for videofluoroscopy swallowing studies? An observational mixed-methods study using the theoretical framework of acceptability.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Williamson Lauren, Lin Michelle, Van Veenendaal Nicholas, Withiel Toni, Nguyen Daniel, D'Souza Aruska N
Аннотация
PURPOSE: Videofluoroscopic swallowing studies traditionally use barium sulphate and remains the gold standard for evaluating swallowing disorders. Due to a global shortage, this study investigates the acceptability of iohexol as an alternative.
METHOD: An observational mixed-method study in a quaternary hospital. Speech-language pathologists rated 294 swallows across 70 videofluoroscopic swallowing studies on a 5-point Likert scale assessing visibility, while blinded to the contrast used (barium or iohexol). Speech-language pathologists experienced with both agents also completed a qualitative online survey on contrast acceptability. Both data types were given equal weight in analysis.
RESULT: Fifteen Speech-language pathologists (mean years of experience 6.87, SD = 5.33) completed visibility ratings; 11 completed the acceptability survey. Acceptability was found to be consistency dependent with iohexol preferred for thin fluids; yet acceptability was also influenced by contrast availability, taste, preparation time, and effort, as well as patient aspiration risk. When blinded to the contrast used, speech-language pathologists were more often satisfied with barium (odds ratio 0.51, 95% CI 0.46-0.58); however, for fluids alone, iohexol was rated more satisfactory (odds ratio 1.26, 95% CI 1.07-1.49).
CONCLUSION: Barium sulphate remains preferable for visibility and preparation, but iohexol was also acceptable, particularly for fluids and in situations where barium is unavailable.
METHOD: An observational mixed-method study in a quaternary hospital. Speech-language pathologists rated 294 swallows across 70 videofluoroscopic swallowing studies on a 5-point Likert scale assessing visibility, while blinded to the contrast used (barium or iohexol). Speech-language pathologists experienced with both agents also completed a qualitative online survey on contrast acceptability. Both data types were given equal weight in analysis.
RESULT: Fifteen Speech-language pathologists (mean years of experience 6.87, SD = 5.33) completed visibility ratings; 11 completed the acceptability survey. Acceptability was found to be consistency dependent with iohexol preferred for thin fluids; yet acceptability was also influenced by contrast availability, taste, preparation time, and effort, as well as patient aspiration risk. When blinded to the contrast used, speech-language pathologists were more often satisfied with barium (odds ratio 0.51, 95% CI 0.46-0.58); however, for fluids alone, iohexol was rated more satisfactory (odds ratio 1.26, 95% CI 1.07-1.49).
CONCLUSION: Barium sulphate remains preferable for visibility and preparation, but iohexol was also acceptable, particularly for fluids and in situations where barium is unavailable.